KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Halozyme Therapeutics (HALO) Interest Coverage Ratio (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Interest Coverage Ratio for 13 consecutive years, with 18.91 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 148.93% to 18.91 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25.87 through Dec 2025, down 15.1% year-over-year, with the annual reading at 25.87 for FY2025, 15.1% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 18.91 at Halozyme Therapeutics, down from 50.73 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 53.11 in Q2 2021, with the low at 18.91 in Q4 2025.
  • Average Interest Coverage Ratio over 5 years is 26.69, with a median of 25.87 recorded in 2021.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 4384.26% in 2021, then plummeted 148.93% in 2025.
  • Over 5 years, Interest Coverage Ratio stood at 27.51 in 2021, then crashed by 40.74% to 16.3 in 2022, then grew by 18.72% to 19.36 in 2023, then skyrocketed by 99.72% to 38.66 in 2024, then tumbled by 148.93% to 18.91 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 18.91, 50.73, and 46.07 for Q4 2025, Q3 2025, and Q2 2025 respectively.